December 8 2025
Multiple myeloma causes severe bone damage in over 80% of patients. New drugs like romosozumab and anti-DKK1 agents are now showing they can rebuild bone - not just stop its destruction. Learn how these breakthroughs are changing treatment.
SEE MORE
